Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12861 | 876 | 38.2 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
429 | 3 | SPHINGOSINE 1 PHOSPHATE//CERAMIDE//SPHINGOLIPIDS | 27734 |
2112 | 2 | PLATELET ACTIVATING FACTOR//LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2//PAF | 5117 |
12861 | 1 | LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2//LP PLA2//PLATELET ACTIVATING FACTOR ACETYLHYDROLASE | 876 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 | authKW | 3696417 | 17% | 73% | 146 |
2 | LP PLA2 | authKW | 1977572 | 9% | 72% | 79 |
3 | PLATELET ACTIVATING FACTOR ACETYLHYDROLASE | authKW | 1002133 | 7% | 50% | 58 |
4 | PAF ACETYLHYDROLASE | authKW | 996428 | 6% | 53% | 54 |
5 | PLA2G7 | authKW | 418275 | 1% | 100% | 12 |
6 | DARAPLADIB | authKW | 405892 | 2% | 61% | 19 |
7 | PAF AH | authKW | 374897 | 2% | 51% | 21 |
8 | LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 LP PLA2 | authKW | 358518 | 1% | 86% | 12 |
9 | ACETYLHYDROLASE | authKW | 240263 | 2% | 38% | 18 |
10 | LP PLA2 INHIBITOR | authKW | 174281 | 1% | 100% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 3234 | 18% | 0% | 160 |
2 | Cardiac & Cardiovascular System | 1694 | 18% | 0% | 159 |
3 | Medical Laboratory Technology | 631 | 5% | 0% | 41 |
4 | Biochemistry & Molecular Biology | 568 | 24% | 0% | 214 |
5 | Nutrition & Dietetics | 316 | 6% | 0% | 49 |
6 | Hematology | 218 | 6% | 0% | 49 |
7 | Endocrinology & Metabolism | 165 | 7% | 0% | 57 |
8 | Medicine, Research & Experimental | 111 | 5% | 0% | 47 |
9 | Biophysics | 97 | 5% | 0% | 43 |
10 | Obstetrics & Gynecology | 65 | 3% | 0% | 30 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SCI NUTR DIETET | 156832 | 2% | 30% | 15 |
2 | BASIC PL UNIT | 78425 | 0% | 75% | 3 |
3 | BAYLOR LIPID ATHEROSCLEROSIS CLIN | 69712 | 0% | 100% | 2 |
4 | CLIN SCIINTERNAL MED GRP | 69712 | 0% | 100% | 2 |
5 | SEOUL EULJI HOSP MED | 69712 | 0% | 100% | 2 |
6 | SW MED BIOCHEM 5323 HARRY HINES BLVD | 61962 | 0% | 44% | 4 |
7 | LEADING CLIN NUTRIGENET NUTRIGENOM | 52281 | 0% | 50% | 3 |
8 | LIPID METAB ATHEROSCLEROSIS | 47370 | 1% | 12% | 11 |
9 | CARDIOVASC EXCELLENCE DRUG DISCOVERY | 44812 | 0% | 43% | 3 |
10 | 348 | 34856 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING | 15205 | 1% | 4% | 11 |
2 | ATHEROSCLEROSIS | 6313 | 5% | 0% | 44 |
3 | LIPIDS IN HEALTH AND DISEASE | 4503 | 2% | 1% | 14 |
4 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 3120 | 3% | 0% | 26 |
5 | CURRENT ATHEROSCLEROSIS REPORTS | 2570 | 1% | 1% | 7 |
6 | JOURNAL OF CLINICAL LIPIDOLOGY | 1919 | 1% | 1% | 6 |
7 | JOURNAL OF LIPID RESEARCH | 1774 | 2% | 0% | 21 |
8 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 1282 | 1% | 0% | 10 |
9 | BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM | 802 | 1% | 0% | 5 |
10 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 684 | 1% | 0% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 | 3696417 | 17% | 73% | 146 | Search LIPOPROTEIN+ASSOCIATED+PHOSPHOLIPASE+A2 | Search LIPOPROTEIN+ASSOCIATED+PHOSPHOLIPASE+A2 |
2 | LP PLA2 | 1977572 | 9% | 72% | 79 | Search LP+PLA2 | Search LP+PLA2 |
3 | PLATELET ACTIVATING FACTOR ACETYLHYDROLASE | 1002133 | 7% | 50% | 58 | Search PLATELET+ACTIVATING+FACTOR+ACETYLHYDROLASE | Search PLATELET+ACTIVATING+FACTOR+ACETYLHYDROLASE |
4 | PAF ACETYLHYDROLASE | 996428 | 6% | 53% | 54 | Search PAF+ACETYLHYDROLASE | Search PAF+ACETYLHYDROLASE |
5 | PLA2G7 | 418275 | 1% | 100% | 12 | Search PLA2G7 | Search PLA2G7 |
6 | DARAPLADIB | 405892 | 2% | 61% | 19 | Search DARAPLADIB | Search DARAPLADIB |
7 | PAF AH | 374897 | 2% | 51% | 21 | Search PAF+AH | Search PAF+AH |
8 | LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 LP PLA2 | 358518 | 1% | 86% | 12 | Search LIPOPROTEIN+ASSOCIATED+PHOSPHOLIPASE+A2+LP+PLA2 | Search LIPOPROTEIN+ASSOCIATED+PHOSPHOLIPASE+A2+LP+PLA2 |
9 | ACETYLHYDROLASE | 240263 | 2% | 38% | 18 | Search ACETYLHYDROLASE | Search ACETYLHYDROLASE |
10 | LP PLA2 INHIBITOR | 174281 | 1% | 100% | 5 | Search LP+PLA2+INHIBITOR | Search LP+PLA2+INHIBITOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MIKLISHANSKAYA, SV , LYAKISHEV, AA , KUKHARCHUK, VV , (2013) CLINICAL ROLE OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2.KARDIOLOGIYA. VOL. 53. ISSUE 3. P. 59 -70 | 115 | 88% | 1 |
2 | TELLIS, CC , TSELEPIS, AD , (2014) PATHOPHYSIOLOGICAL ROLE AND CLINICAL SIGNIFICANCE OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A(2) (LP-PLA(2)) BOUND TO LDL AND HDL.CURRENT PHARMACEUTICAL DESIGN. VOL. 20. ISSUE 40. P. 6256 -6269 | 102 | 77% | 6 |
3 | STAFFORINI, DM , ROSENSON, RS , (2012) MODULATION OF OXIDATIVE STRESS, INFLAMMATION, AND ATHEROSCLEROSIS BY LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A(2).JOURNAL OF LIPID RESEARCH. VOL. 53. ISSUE 9. P. 1767 -1782 | 109 | 65% | 50 |
4 | STAFFORINI, DM , (2009) BIOLOGY OF PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE (PAF-AH, LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A(2)).CARDIOVASCULAR DRUGS AND THERAPY. VOL. 23. ISSUE 1. P. 73 -83 | 77 | 78% | 98 |
5 | GREGSON, J , STIRNADEL-FARRANT, HA , DOOBAREE, IU , KORO, C , (2012) VARIATION OF LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 ACROSS DEMOGRAPHIC CHARACTERISTICS AND CARDIOVASCULAR RISK FACTORS: A SYSTEMATIC REVIEW OF THE LITERATURE.ATHEROSCLEROSIS. VOL. 225. ISSUE 1. P. 11 -21 | 77 | 80% | 13 |
6 | EPPS, KC , WILENSKY, RL , (2011) LP-PLA(2)- A NOVEL RISK FACTOR FOR HIGH-RISK CORONARY AND CAROTID ARTERY DISEASE.JOURNAL OF INTERNAL MEDICINE. VOL. 269. ISSUE 1. P. 94-106 | 62 | 87% | 26 |
7 | CAI, AP , ZHENG, DD , QIU, RF , MAI, WY , ZHOU, YL , (2013) LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA(2)): A NOVEL AND PROMISING BIOMARKER FOR CARDIOVASCULAR RISKS ASSESSMENT.DISEASE MARKERS. VOL. 34. ISSUE 5. P. 323-331 | 60 | 85% | 15 |
8 | TSELEPIS, AD , TELLIS, CC , (2009) THE ROLE OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A(2) IN ATHEROSCLEROSIS MAY DEPEND ON ITS LIPOPROTEIN CARRIER IN PLASMA.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. VOL. 1791. ISSUE 5. P. 327 -338 | 84 | 62% | 64 |
9 | KARASAWA, K , HARADA, A , SATOH, N , INOUE, K , SETAKA, M , (2003) PLASMA PLATELET ACTIVATING FACTOR-ACETYLHYDROLASE (PAF-AH).PROGRESS IN LIPID RESEARCH. VOL. 42. ISSUE 2. P. 93-114 | 88 | 70% | 87 |
10 | TSELEPIS, AD , CHAPMAN, MJ , (2002) INFLAMMATION, BIOACTIVE LIPIDS AND ATHEROSCLEROSIS: POTENTIAL ROLES OF A LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2, PLATELET ACTIVATING FACTOR-ACETYLHYDROLASE.ATHEROSCLEROSIS SUPPLEMENTS. VOL. 3. ISSUE 4. P. 57 -68 | 77 | 71% | 183 |
Classes with closest relation at Level 1 |